The 2015 First Oncology Precision Medicine Forum was successfully held in Beijing.

October 30, 2015 - November 1, 2015, co-sponsored by the Central Medical and Health Committee of the Communist Party of China and the Scientific Anti-Cancer Promotion Committee of the China Life Care Association, hosted by Beijing Baofa Cancer Hospital, and the "First 2015 Cancer Precision Medicine Forum" supported by the chief media of the Health Times was successfully held in Beijing.
the forum invited more than 30 oncologists from home and abroad, including Dr. Ivor Royston, a well-known American oncologist and health adviser to former U.S. President Bill Clinton's administration, and attracted more than 500 colleagues from the field of oncology in China.
Precision Medicine is a new model of diagnosis, treatment, prevention and care for diseases of individuals or specific groups of people, taking into account individual differences, and in layman's terms, providing the right treatment for the right patients at the right time.
precision medicine is a medical model based on big genomic data, the primary goal is to redefine disease. The traditional disease classification is mainly based on clinical symptoms and sign stakes, while the disease classification of precision medicine should consider the molecular markers, genetic polymorphism, living environment and lifestyle related information based on clinical symptoms and signs, and finally form a new model of disease classification based on molecular biology.The
Cancer Precision Medicine Program hopes to use genome sequencing and information analysis to screen and identify mutations in "drivegene" and other related genes from the cancer genome to explain cancer cell resistance to drugs, clarify the genomic heterogeneity of cancer, parse the mechanisms of cancer recurrence and metastasis, and establish new guidelines for the treatment of cancer drugs;
the Forum is divided into academic reports and breakout sessions, and the concept of precision medicine will continue throughout the Conference. Jiang Zuojun, deputy secretary-general of the Cppcc National Committee and executive vice-chairman of the Central Committee of the Communist Party of China, pointed out that the current congress will be discussed in depth on the current problems and related policies of cancer treatment, specifically on how to do a good job in cancer prevention, diagnosis, treatment, as well as cancer clinical research, method innovation, drug approval, Chinese medicine anti-cancer and many other issues, the Central Committee of the Communist Party of China will put forward relevant views, suggestions after finishing to the relevant ministries, and jointly promote the development of cancer and other issues.
in the academic report section, Yu Baofa, a former assistant professor at the University of California, San Diego School of Medicine and a renowned oncologist, proposed a combination of physical and chemical, local tumor cell inactivation-based minimally invasive precision immunotherapy - slow release library therapy, which is guided by imaging equipment, the transdermal needle with very fine puncture needles will be the anti-cancer drug - slow release agent - immunoalysis composed of drug composition injection to the tumor site. The image-guided needle achieves the location accuracy of the solid tumor, and the program injection achieves quantitative precision of the treatment.
to promote clinical research on pancreatic cancer treatment, the Scientific Anti-Cancer Promotion Committee of the China Life Care Association has established the "Special Fund for the Treatment of Pancreatic Cancer Relief Bank", which received the first batch of 1.3 million yuan from Baofa and others at the scene of the conference.
at the opening ceremony of the Forum, also held the "free re-release library treatment of 30 cases of pancreatic cancer patients" launch ceremony, dedicated to 30 pancreatic cancer patients slow release library treatment, and set up a third-party identification committee composed of domestic and foreign oncologists, responsible for the implementation of the program throughout the review, supervision and demonstration.
all documents labeled as "Health Times Network" are original content of The Health Times, reproduced please indicate the source of "Health Times Network" and attach a link to the original text. For content collaboration, please contact 010-65369672.
.